First evidence-based, multidisciplinary treatment guidelines for brain metastases patients to be published

Anthony Asher, MD, FACS, of Carolina Neurosurgery & Spine Associates in Charlotte, NC, has co-authored the first evidence-based, multidisciplinary treatment guidelines for brain metastases patients. These guidelines were recently presented at the Congress of Neurological Surgeons 2009 Annual Meeting in New Orleans, and were developed over the last year by a 20-member panel from various medical specialties. Members of the panel analyzed 25,000 brain tumor studies and then utilized 400 of them to make their final guideline decisions. The new guidelines will be published in a special issue of the Journal of Neuro-Oncology in December.

"This important document defines the current scientifically-based standard of treatment for patients with the most common form of brain tumor, and also serves as a tool to advance care by helping generate the next generation of clinical trials," said Dr. Asher. "Thousands of patients are afflicted with this disorder each year in the Charlotte area alone. Along with our oncology colleagues, we are steadily improving care for these patients and allowing them to enjoy a greater quality of life following the diagnosis of metastatic brain cancer."

"These guidelines clearly point to the importance of a multidisciplinary approach in the treatment of metastatic brain disease," said Renee P. Kelly, RN BSN, who recently joined Carolina Neurosurgery & Spine Associates as the region's first Brain Tumor Navigator. This position involves data collection, communication, education, and care for brain tumor patients and their families.

SOURCE Carolina Neurosurgery & Spine Associates

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Brain volume loss linked to Alzheimer's treatment may be caused by amyloid plaque removal